Last reviewed · How we verify
Mineral trioxide aggregate — Competitive Intelligence Brief
marketed
Dentistry/Endodontics
Small molecule
Live · refreshed every 30 min
Target snapshot
Mineral trioxide aggregate (Mineral trioxide aggregate) — Universidad de los Andes, Chile. Mineral trioxide aggregate (MTA) is a biocompatible cement that sets through a hydration reaction, creating a hard matrix that seals and promotes healing in endodontic and dental applications.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mineral trioxide aggregate TARGET | Mineral trioxide aggregate | Universidad de los Andes, Chile | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mineral trioxide aggregate CI watch — RSS
- Mineral trioxide aggregate CI watch — Atom
- Mineral trioxide aggregate CI watch — JSON
- Mineral trioxide aggregate alone — RSS
Cite this brief
Drug Landscape (2026). Mineral trioxide aggregate — Competitive Intelligence Brief. https://druglandscape.com/ci/mineral-trioxide-aggregate. Accessed 2026-05-20.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab